BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide fragment corresponding to a partial sequence of a larger endogenous gastric protein complex known as Body Protection Compound. The peptide is characterized by a proline-rich sequence that contributes to conformational rigidity and resistance to proteolytic degradation in aqueous experimental systems. Within laboratory research environments, BPC-157 has been employed as a molecular probe to investigate fibroblast proliferation, endothelial cell migration, extracellular matrix dynamics, angiogenic signaling, and cytoskeletal organization. Mechanistic investigations in preclinical models indicate modulation of VEGFR2-associated signaling cascades and downstream nitric oxide pathways. Additional in-vitro findings describe phosphorylation changes in focal adhesion signaling proteins involved in cell migration and cytoskeletal anchoring. Published preclinical literature documents investigations across multiple experimental systems, including rodent models examining vascular recruitment, gastrointestinal structural integrity, and connective extracellular matrix remodeling under controlled laboratory conditions. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Molecular Formula: C₆₂H₉₈N₁₆O₂₂ Molecular Weight: 1419.56 g/mol PubChem CID: 108101 All applications are limited to non-clinical research systems. Not for human consumption.